Zobrazeno 1 - 10
of 18
pro vyhledávání: '"M J, Staruch"'
Publikováno v:
The Journal of Immunology. 152:992-1003
Rapamycin (RAP) inhibits several biologic responses in the YAC-1 T cell lymphoma, including the serum-driven proliferation and cyclin A mRNA expression, the induction of Ly-6E Ag expression by IFN, and the induction of IFN-gamma production by IL-1. R
Publikováno v:
The Journal of Immunology. 144:1418-1424
The structurally related immunosuppressive macrolides FK-506 and rapamycin (RAP) were previously shown to inhibit T cell stimulation through different mechanisms. FK-506 acts similarly to cyclosporin A (CsA) and prevents IL-2 production and IL-2R exp
Publikováno v:
The Journal of Immunology. 144:251-258
FK-506 and the structurally related macrolide rapamycin (RAP) were investigated in comparison with cyclosporin A (CsA) for their immunosuppressive effects on murine T cells. All three agents suppressed the proliferation of splenic T cells triggered b
Autor:
F J, Dumont, H, Ok, S, Lin, C A, Kastner, J, Cryan, M M, Martin, G, Wiederrecht, M J, Staruch
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 276(3)
FK-506 blocks T cell activation by preventing lymphokine gene transcription through formation of a complex with FKBP12 that inhibits calcineurin phosphatase activity. Immunosuppressive FK-506 analogs (agonists) have been generated whose potency corre
Publikováno v:
Transplantation proceedings. 23(6)
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 144(10)
The YAC T cell lymphoma normally does not express Ly-6E mRNA or Ly-6E surface molecules but can be induced to do so on incubation with either IFN-gamma or IFN-alpha/beta. This system afforded a model to assess the possible role of protein kinase C (P
Autor:
D D Wood, E K Bayne, M B Goldring, M Gowen, D Hamerman, J L Humes, E J Ihrie, P E Lipsky, M J Staruch
Publikováno v:
The Journal of Immunology. 134:895-903
The supernatants of human monocytes incubated with endotoxin are able to stimulate the proliferation of murine thymocytes in the presence of PHA. This is known as LAF (lymphocyte activating factor) activity and is a characteristic activity of interle
Publikováno v:
The Journal of Immunology. 143:1580-1583
A novel macrolide antibiotic, FK-506, isolated from Streptomyces tsukubaensis, has been shown to be a potent immunosuppressive agent in vivo and in vitro. FK-506 shares a number of immunosuppressive properties with the cyclic peptide, cyclosporin A (
Autor:
M J Staruch, D D Wood
Publikováno v:
The Journal of Immunology. 128:155-160
The possibility that the adjuvanticity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) is under genetic control in mice was examined. It was observed that MDP markedly enhances the secondary antibody response of BALB/c mice to bovine albumin but has
Autor:
M J, Staruch, D D, Wood
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 130(5)
Interleukin 1 (IL 1) was shown to enhance in vivo secondary antibody responses of mice to a protein antigen. The activity was found to be dose and time dependent. The maximum enhancing effect was obtained with 2000 LAF units of IL 1 given 2 hr after